Clinical trial
Repositionable Lotus Edge™ Valve System - Post Market Evaluation of Real World Clinical Outcomes
NCT04009720 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Repositionable Lotus Edge™ Valve System - Post Market Evaluation of Real World Clinical Outcomes
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Observational
- Overall status
- Terminated
- Start date
- October 11, 2019
- Completion date
- June 2, 2021
- Enrollment
- 200 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.